TheraSkin
TheraSkin is a Brazilian pharmaceutical and dermocosmetics company, family-owned since 1931, offering 40+ dermatology products across skincare, medications, and supplements distributed through Brazilian pharmacy retail networks and direct-to-consumer e-commerce.
- Company typePrivate
- Founded1996
- HeadquartersSanto André, Brazil
- Headcount251–500
- GTM typeB2C
- OfferingHardware or Manufacturing
What TheraSkin does
TheraSkin (Theraskin Farmacêutica Ltda.) is a Brazilian pharmaceutical and dermocosmetics company, family-owned by the Scavarelli family, with operational roots in a pharmacy founded in 1931 and the TheraSkin consumer brand launched in 1996. The company is headquartered in São Bernardo do Campo, São Paulo, and employs 251–500 people. It serves Brazilian consumers with dermatology-focused products spanning dermocosmetics, medications, and nutritional supplements, distributed through the country's pharmacy and drugstore retail channel and direct-to-consumer e-commerce.
The product portfolio comprises 40+ SKUs built on proprietary formulation platforms including Oxicontrol, Biocalm, Age Complex QR, Syndet, One Tone System, and Eco-Boost, which TheraSkin uses to differentiate across skincare, sensitive-skin, infant, sun-care, skin-lightening, and oncology-support categories. In 2016, the company entered an IBM Watson cognitive-computing partnership for R&D — described as the first such arrangement for a Latin American dermocosmetics company — and used the platform to develop Euryale C, positioned as the first Brazilian dermocosmetic developed with AI support. Other recent additions include a 2018 skin-lightening line leveraging the One Tone System and the UV-Less sunscreen range offering multiple shade variants for diverse Brazilian skin tones.
TheraSkin's business model is consumer-product B2C: revenue is generated through unit sales across a diversified portfolio of consumer segments (general skincare, infant care, sensitive skin, sun protection, skin tone unification, and therapeutic skin support via the Programa Suavidade oncology program) sold through Brazilian pharmacy retail and DTC e-commerce. Sustainability infrastructure (eureciclo certification in 2017, Renewable Energy Certificate in 2022) supports ESG positioning increasingly required by pharmacy retail buyers. The company operates exclusively in Brazil, with no visible geographic expansion signals in the available data.
TheraSkin firmographics
Firmographics- Name
- TheraSkin
- Legal name
- Theraskin Farmacêutica Ltda.
- Website
- https://theraskin.com.br
- Company type
- Private
- Founded year
- 1996
- Operating status
- Operating
- Headcount range
- 251–500 employees
- Short description
- TheraSkin is a Brazilian pharmaceutical and dermocosmetics company, family-owned since 1931, offering 40+ dermatology products across skincare, medications, and supplements distributed through Brazilian pharmacy retail networks and direct-to-consumer e-commerce.
- Ownership category
- akta.pro rank
TheraSkin industry classification
Industry- Product category
- Dermocosmetics and Dermatological Pharmaceuticals
- NAICS
- Soap and Cleaning Compound Manufacturing (32561), Cosmetics, Beauty Supplies, and Perfume Retailers (456120), Health and Personal Care Retailers (456)
- SIC
- Perfumes, Cosmetics & Other Toilet Preparations (2844), Soap, Detergents, Cleang Preparations, Perfumes, Cosmetics (2840), Medicinal Chemicals & Botanical Products (2833)
- akta.pro primary industry
- Dermocosmetics & Medical-Grade Skincare (CRABAAAF)
- akta.pro secondary industries
- Dermatology & Aesthetics Pharmaceuticals (HLAIAAAK), Dermatology OTC & Skin Health (Acne Treatments, Eczema/Psoriasis OTC, Antifungals, Wart Removal) (CRADAMAF)
Keywords
Where TheraSkin is headquartered
LocationHeadquarters
- HQ city
- Santo André
- HQ country
- Brazil
- HQ region
- Latin America
Offices1 record
Markets served
TheraSkin business model
Business model- GTM type
- B2C
- Offering type
- Hardware or Manufacturing
- Cost components
- Supply Chain, Operations, Personnel, Technology or R&D, Marketing or Sales, Infrastructure
Revenue model
- Dermocosmetics: TheraSkin generates revenue through the sale of dermocosmetic products including anti-aging serums (Euryale QR, Euryale C), brightening products (Klassis TX+, Klassis Specialle), acne treatments (Cleany, Papuless, Theracne), moisturizers (Klavie Clinical, Kalima), infant care (Cetrilan), and sunscreens (UV-Less). Products are sold through pharmacies and direct-to-consumer via website.
- Medicamentos (Pharmaceuticals): Sale of over-the-counter and prescription pharmaceutical products including Vitacid (tretinoin), Hixizine (hydroxyzine), Micolamina (antifungal), Therapsor (hair solution), Verrux, Aloxidil, and Camomilina C for infant teething discomfort.
- Suplementos (Supplements): Sale of nutritional supplements such as Nourkrin for hair loss reduction and strengthening.
Go-to-market motion1 record
Distribution channels2 records
Marketing channels4 records
TheraSkin product offering
Product offeringCore offering
TheraSkin is a Brazilian pharmaceutical company that manufactures and sells dermatological products, including a portfolio of over 40 dermocosmetics (anti-aging serums, brightening products, acne treatments, moisturizers, sunscreens, infant care, and multi-repair lotions) and pharmaceutical medications (Vitacid, Hixizine, Micolamina, Camomilina C, Therapsor, Verrux, Aloxidil). The company sells primarily through retail pharmacies and drugstores across Brazil, supplemented by direct-to-consumer e-commerce via its own website.
Product overview
TheraSkin is a Brazilian pharmaceutical company with over 80 years of history specializing in dermatological products. The company offers a comprehensive portfolio of dermocosmetics organized into categories: Anti-acne (Cleany, Papuless, Theracne), Anti-wrinkle/Aging (Euryale QR, Euryale C), Brightening/Clareadores (Klassis TX+, Klassis Specialle, Klassis Emulgel, Klassis R), Moisturizing/Hydration (Klavie Clinical line, Kalima), Infant care (Cetrilan line), Multi-repair (Amilia line), and Sunscreen (UV-Less with 6 shades). Additionally, TheraSkin manufactures prescription medications including Vitacid, Hixizine, Micolamina, and offers supplements like Nourkrin for hair loss. The product portfolio exceeds 40 products. The company differentiates through pharmaceutical expertise, innovation with AI-assisted formulation (Euryale C), and IBM Watson cognitive computing for R&D.
Differentiator
Problem solved
Functional benefit
Brands
- Euryale: Anti-aging serum line including Euryale QR (night serum) and Euryale C (vitamin C serum)
- Klassis
- Cetrilan
- UV-Less
- Cleany
- Klaviê Clinical
- Amilia
- Papuless
- Theracne
- Camomilina C
- Kalima
- Nourkrin
- Vitacid
- Hixizine
- Micolamina
- Therapsor
- Verrux
- Aloxidil
Products and services
- Euryale QR Anti-wrinkle night facial serum with antioxidant action that reduces deep wrinkles and expression lines, formulated with Retinol, Isoquercetin, Vitamin E, Hyaluronic Acid, and Niacinamide. Targeted at adult consumers concerned with signs of cutaneous aging.
- Euryale C Facial serum with 10% stabilized pure Vitamin C using exclusive Ação Oxicontrol technology for antioxidant protection. Designed for all skin types to improve appearance of fine lines and promote uniform, luminous skin. Marketed as the first Brazilian dermocosmetic developed with AI assistance.
- Klassis TX+ Multifunctional dermobrightening facial serum combining tranexamic acid and Revivyl for progressive reduction of dark spots and skin tone uniformity through cellular renewal. Targeted at consumers with hyperpigmentation and uneven skin tone.
- Klassis Specialle Acid-free brightening serum for sensitive areas such as face, underarms, and groin, using a pro-brightening complex and Oligopeptide-34 for gradual skin tone unification. Clinical studies cited 73.33% improvement in skin appearance at 28 days and 84.38% lightening at 84 days. Targeted at consumers seeking brightening for sensitive skin areas.
- Klassis Emulgel Brightening gel cream combining Arbutin, Kojic Acid, Lactic Acid, and Glycolic Acid for cellular renewal and skin tone uniformity. Targeted at consumers with oily or mixed skin seeking brightening without heavy textures.
- Klassis R Brightening cream for mature or photoaged skin with Retinoate of Hydroxypinacolone, Alpha-Arbutin, Niacinamide, Hyaluronic Acid, and Polyglutamic Acid for overnight anti-aging and brightening care. Targeted at consumers with photoaging concerns.
- Amilia Repair Prebiotic multi-repair lotion with exclusive Biocalm technology combining prebiotic ingredients to balance skin microbiota, aiding hydration, cutaneous comfort, and barrier maintenance. Targeted at consumers with sensitive, irritated, or sensitized skin.
- Amilia Talco Liquido Liquid talc with Bisabolol and Kaolin for daily comfort, moisture control, and velvety finish on sensitive and delicate skin. Safe for babies and adults. Targeted at consumers seeking gentle daily care for sensitive skin.
- Cleany Controle Cleansing gel with Syndet technology and Hyaluronic Acid for gentle cleansing that controls excess oiliness without drying. Targeted at consumers with mixed and oily skin.
- Cleany Concentrado Cleansing gel with Syndet technology containing Salicylic Acid, Zinc PCA, and Hyaluronic Acid for deep cleansing and pore unclogging. Targeted at consumers with oily and acne-prone skin.
- Papuless Anti-acne daily-use gel with Niacinamide (Vitamin B3) for oil control, pore refinement, and skin texture uniformity. Targeted at consumers with acne-prone skin.
- Theracne Barra Bar soap with Zinc PCA and Melaleuca Oil for daily facial cleansing of oily and acne-prone skin, removing impurities and controlling oil.
- Theracne Gel Exfoliating gel with Eco-Boost biodegradable cellulose microgranules for gentle physical exfoliation of oily and acne-prone skin with reduced environmental impact.
- UV-Less Sun Protection Line Sunscreen facial gel cream line with SPF 70, UVA, UVB, and visible light protection, featuring One Tone System technology. Available in colorless and tinted versions across multiple skin tone shades, with Hyaluronic Acid, Niacinamide, Allantoin, and Vitamin E. Targeted at consumers seeking broad-spectrum facial sun protection, including those with oily skin or darker skin tones needing inclusive tint options.
- Klavie Clinical Line Clinical hydration line (syndet liquid soap, daily moisturizing lotion, and 24-hour moisturizing cream) with SymCalmin and SymRepair technologies, free from fragrance, colorants, and preservatives. Suitable for atopic, diabetic, and oncological skin. Targeted at consumers with very dry, sensitive, and sensitized skin requiring hypoallergenic daily care.
- Kalima Sabonete Vegetable-base bar soap with three natural butters — Shea (anti-aging and moisturizing), Illipe (barrier restoration), and Mango (surface reinforcement and healing). Targeted at consumers with normal to dry and sensitive skin.
- Cetrilan Infant Care Line Infant care line including diaper rash prevention cream (with Calendula Oil, Zinc Oxide, Lanolin, and Almond Oil, available in 40g and 120g), gentle bar soap, and liquid soap for baby hygiene. Formulated for delicate baby and child skin. Targeted at parents and caregivers of infants.
- Camomilina C Oral medication in capsules for babies from 4 months, indicated for relief of symptoms associated with first teething (inflammation). Contains Chamomile, Licorice, Vitamin C, and Vitamin D3. Targeted at parents seeking teething symptom relief for infants.
- Vitacid Line Tretinoin-based topical medication line (gel and cream formulations, including XT and Plus variants) for dermatological treatments such as acne and photoaging. Targeted at patients under dermatological supervision.
- Hixizine Line Hydroxyzine-based medication line available in coated tablet and syrup forms, indicated for dermatological conditions such as pruritus and anxiety-related skin symptoms. Targeted at patients under medical supervision.
- Micolamina Line Antifungal medication line (cream, nail polish, and spray solution formulations) for treatment of superficial fungal infections including onychomycosis. Targeted at patients with fungal skin or nail infections.
- Nourkrin Nutritional supplement with natural ingredients for reduction of hair loss and strengthening and growth of existing hair. Targeted at consumers experiencing hair thinning or hair loss.
Quantifiable outcome
- 73.33% improvement in skin appearance in 28 days with Klassis Specialle
- +1 more outcomes
Companies that use TheraSkin
Customer profileSegments5 records
Ideal customer profiles4 records
TheraSkin technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability2 records
Feature8 records
TheraSkin partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- IBM WatsoncoreStrategic technology partnership where TheraSkin became the first healthcare company in Latin America to use IBM Watson cognitive computing for research and development of new medications and skincare products. This AI partnership enhanced product formulation capabilities and innovation speed.
Scale indicators7 records
Recent moves10 records
Expansion highlights5 records
TheraSkin competitors and assessment
Company assessmentRegional players
- Aché Laboratórios: Large Brazilian pharmaceutical company with dermocosmetic and OTC lines sold through Brazilian pharmacies; comparable as a domestic pharma competitor operating in the same retail channel as TheraSkin.
- Eurofarma: Brazilian multinational pharmaceutical company with prescription, OTC, and dermocosmetic lines distributed across Latin America; comparable as a regional pharma competitor with overlapping dermatology categories and pharmacy-channel distribution.
Direct peers
- Bioderma: NAOS-owned French dermo-cosmetic brand with Brazilian pharmacy presence, competing across sensitive skin, acne, and brightening categories that intersect with TheraSkin's Cleany, Papuless, and Klassis lines.
- La Roche-Posay: L'Oréal-owned dermocosmetic brand distributed through Brazilian pharmacies targeting sensitive and dermatological skincare, directly competing with TheraSkin's Klavie Clinical and Amilia lines.
- Eucerin: Beiersdorf dermocosmetic brand sold in Brazilian pharmacies, with strong positions in hydration, sun care, and anti-pigmentation that overlap with TheraSkin's UV-Less and Klavie portfolios.
- Vichy: L'Oréal-owned dermo-skincare brand sold in Brazilian pharmacies, competing across anti-aging, brightening, and sensitive-skin categories that overlap with TheraSkin's Euryale and Klassis ranges.
- CeraVe: L'Oréal-owned skincare brand focused on ceramides and barrier repair, distributed in Brazilian pharmacies and directly overlapping with TheraSkin's Klavie Clinical and Amilia Repair sensitive-skin offerings.
- Cetaphil: Galderma-owned sensitive-skin cleanser and moisturizer brand sold in Brazilian pharmacies, competing head-to-head with TheraSkin's syndet-based cleansers and Klavie Clinical moisturizers.
- RoC: Anti-aging-focused skincare brand with retinol heritage and pharmacy distribution, comparable to TheraSkin's Euryale QR retinol-based anti-wrinkle serum.
Broad incumbents
- Galderma: Global dermatology-focused pharmaceutical and skincare company; broader portfolio spanning prescription dermatology and consumer skincare, comparable to TheraSkin's combined dermocosmetic + pharmaceutical (Vitacid, Hixizine) positioning.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat3 records
Key risks6 records
Key highlights7 records
Customer concentration
TheraSkin social profiles
Digital presenceTheraSkin compliance and trust
Trust signalCompliance3 records
TheraSkin financial estimates
Financial estimateRevenue estimate
Valuation estimate
TheraSkin leadership team
Management profileNumber of profiles
Profiles2 records
TheraSkin funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
TheraSkin M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about TheraSkin
What does TheraSkin do?
TheraSkin is a Brazilian pharmaceutical company that manufactures and sells dermatological products, including a portfolio of over 40 dermocosmetics (anti-aging serums, brightening products, acne treatments, moisturizers, sunscreens, infant care, and multi-repair lotions) and pharmaceutical medications (Vitacid, Hixizine, Micolamina, Camomilina C, Therapsor, Verrux, Aloxidil). The company sells primarily through retail pharmacies and drugstores across Brazil, supplemented by direct-to-consumer e-commerce via its own website.
Is TheraSkin a public or private company?
TheraSkin is a private company. It is classified as family owned and is currently operating.
When was TheraSkin founded?
TheraSkin was founded in 1996. It employs 251 to 500 people.
Where is TheraSkin based?
TheraSkin is headquartered in Santo André, Brazil, in the Latin America region.
How does TheraSkin make money?
Three revenue lines are on record. Dermocosmetics are the primary driver. The others are medicamentos (Pharmaceuticals) and suplementos (Supplements).
Who are TheraSkin's main competitors?
Regional players on record are Aché Laboratórios and Eurofarma. Direct peers are Bioderma, La Roche-Posay, Eucerin, Vichy, CeraVe, Cetaphil and RoC. Galderma is listed as a broad incumbent.
Does TheraSkin have an API?
No public API is recorded for TheraSkin.
What industry is TheraSkin in?
TheraSkin's product category is Dermocosmetics and Dermatological Pharmaceuticals. Its primary akta.pro industry code is CRABAAAF, Dermocosmetics & Medical-Grade Skincare, with a secondary code of HLAIAAAK, Dermatology & Aesthetics Pharmaceuticals. Its NAICS code is 32561 and its SIC code is 2844.